Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-24-000017

Options or other derivatives

  • EVP, Chief Business Officer acquired 30,700 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Baroldi Joseph · EVP, Chief Business Officer

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2024-01-02 Grant or award : show line 1 in the form Non-Qualified Stock Option (right to buy) +27,200 $52.87 2034-01-01 27,200 27,200 D
2024-01-02 Grant or award : show line 2 in the form Non-Qualified Stock Option (right to buy) +3,500 $52.87 2034-01-01 3,500 3,500 I
Loading xslF345X05/edgardoc.xml…